We are live on ! Find out more
RBOT

Vicarious Surgical

Delisted

RBOT was delisted on the 2nd of March, 2026.

30 hedge funds and large institutions have $23.7M invested in Vicarious Surgical in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more capital invested

Capital invested by funds: $10.4M → $23.7M (+$13.2M)

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

0.88% less ownership

Funds ownership: 35.11%34.23% (-0.88%)

12% less funds holding

Funds holding: 3430 (-4)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
30
Holders Change
-4
Holders Change %
-11.76%
% of All Funds
0.4%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
2
Increased
8
Reduced
5
Closed
6
Calls
Puts
Net Calls
Net Calls Change

RBOT Hedge Fund Activity: Q4 2024 in Review

30 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q4 2024, worth a combined $23.7M — up 126% from $10.4M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of RBOT and 2 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 8 added.

The largest buyer was DnB Asset Management, adding an estimated $38K. The largest seller was DDD Partners, cutting an estimated $478K.

  • 30 institutional investors held Vicarious Surgical (RBOT) as of Q4 2024, down from 34 in Q3 2024.
  • Funds reported $23.7M of Vicarious Surgical stock for Q4 2024, up 126% quarter-over-quarter.
  • 2 funds opened new Vicarious Surgical positions in Q4 2024 and 6 closed out, a net change of -4 holders.
  • The largest Vicarious Surgical buyer in Q4 2024 was DnB Asset Management, an estimated $38K added.
  • The largest Vicarious Surgical seller in Q4 2024 was DDD Partners, an estimated $478K sold.

Based on aggregated 13F filings for Q4 2024.